A new analysis out of Japan says a dementia drug might ease Long COVID fatigue and depression. But it's basically a reanalysis of the same trial that already failed back in 2025, and even where it helped, results were mixed.
The reanalysis splits people by whether they had a reactivated herpesvirus. Evan H. Hirsch, MD breaks down what that virus is actually doing to your brain, why the drug only helped part of the group and made others worse, and why chasing one virus and one brain chemical never gets to the real cause. He also shares how a client recovered by addressing all of the Toxic 5, the five root causes behind almost every case of Long COVID and chronic fatigue.
In this episode, you'll learn:
Why the new Japan analysis is actually a reanalysis of the same JAMA trial that already found no benefit in 110 people, and why results stayed mixed even where it helped
How HHV6B, a herpesvirus that reactivates after COVID, produces a protein called SITH1 that drains acetylcholine and drives brain fog
Why treating one reactivated virus or one brain chemical never resolves Long COVID on its own
What the Toxic 5 are, and why nervous system dysfunction, what Dr. Patrick Porter calls neurological lock, is one of the five root causes
How a client recovered by addressing all five root causes together, not just the reactivated virus driving her brain fog
Podden och tillhörande omslagsbild på den här sidan tillhör
Evan H. Hirsch, MD. Innehållet i podden är skapat av Evan H. Hirsch, MD och inte av,
eller tillsammans med, Poddtoppen.
